Aurobindo Pharma Buys Out JV Partners in South African Subsidiary for INR 119.03 Million

Aurobindo Pharma Ltd. has announced the purchase of the remaining shares of Purple Bellflower Pty Limited, a South African joint venture company, making it a wholly owned subsidiary. The acquisition cost is INR 119.03 million. Purple Bellflower holds 50% shares in Aurobindo Pharma Pty Limited, a South African subsidiary that generates revenue from antiretroviral business. With this acquisition, both Purple Bellflower and Aurobindo Pharma Pty Limited have become 100% step-down subsidiaries of Aurobindo Pharma Ltd.